Neuroscience

Why we cannot translate successful preclinical results to clinical trials and new drugs in Parkinson’s disease

The failure to translate successful preclinical studies to clinical trials and new therapies is a really an enormous... Read more

Connect with us on social media and stay up to date on new articles